Belpointe Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-366
Closed -$3.85K 2358
2023
Q1
$3.85K Hold
366
﹤0.01% 3109
2022
Q4
$12.4K Buy
+366
New +$12.4K ﹤0.01% 2496
2019
Q2
Sell
-198
Closed -$100K 636
2019
Q1
$100K Buy
+198
New +$100K 0.02% 449
2018
Q4
Sell
-134
Closed -$123K 589
2018
Q3
$123K Buy
+134
New +$123K 0.02% 588
2018
Q2
Sell
-132
Closed -$210K 374
2018
Q1
$210K Buy
+132
New +$210K 0.06% 305